CardioNet's mission is to help clinicians prevent morbidity, mortality and disability with rapid diagnosis and treatment, initially focusing our efforts on patients with cardiovascular disease. Working with clinicians and researchers to address unmet needs, CardioNet will continually evolve, introducing new analytic, response and reporting capabilities. CardioNet, headquartered in San Diego, became an operating company in 1999, founded on an innovative, patented technology, the result of years of research and development. In the integration of cardiac monitoring, wireless communications, GPS and proprietary information management technologies, the CardioNet mobile outpatient telemetry system is the first to provide real-time ECG monitoring and 24/7/365 analysis and response for patients--at home, at work or traveling. In February 2002, CardioNet received FDA approval for its core monitoring technology and opened the first CardioNet Service Center in Philadelphia. CardioNet is a venture-backed company whose investors include Hambrecht and; Quist Capital Management, Sanderling, IngleWood Ventures, BioFrontier Partners, IDEO, Guidant Corporation, and Foundation Medical Partners.
This article uses content from
http://www.AboutUs.org
